文献速递胸部CT

新型冠状病毒肺炎患者初始胸部CT或临床特征与临床病程的关联

Association between Initial Chest CT or Clinical Features and Clinical Course in Patients with Coronavirus Disease 2019 Pneumonia.
PubMed 文献 · Korean J Radiol · 2020-01-01

回顾性分析72例新型冠状病毒肺炎住院患者的基线CT与临床资料,评估初始CT表现及临床特征与康复出院的关系。多因素Cox回归显示,基线CT肺严重程度评分>4分和初始淋巴细胞计数降低是影响康复出院的独立因素。

要点

  • 基线CT肺严重程度评分>4分者出院率较低(校正HR=0.41,95%CI 0.18-0.92,P=0.031)。
  • 初始淋巴细胞计数降低者出院率较低(校正HR=0.14,95%CI 0.03-0.60,P=0.008)。
  • 研究期间无患者死亡,32例康复出院,中位住院16天(范围9-25天)。

核心结论

  • 初始评估时肺严重程度评分>4分和淋巴细胞计数降低与新型冠状病毒肺炎住院患者康复出院率显著降低及住院时间延长独立相关。

研究设计与样本

  • 回顾性分析72例新型冠状病毒肺炎住院患者(男39例,年龄46.2±15.9岁)的基线CT及临床和实验室数据。
  • 评估基线CT表现包括肺叶分布、磨玻璃影、实变、线状影及肺严重程度评分。
  • 结局事件为康复出院,记录从症状出现至出院或末次随访的时间,死亡或未康复出院作删失处理。
  • 采用多因素Cox比例风险回归分析初始CT、临床或实验室表现与康复出院的关系,HR<1表示4周时出院率较低且至出院时间较长。

关键影像表现/征象

  • 基线CT评估包括肺叶分布、磨玻璃影、实变、线状影及肺严重程度评分。

诊断标准与关键数值

  • 基线CT肺严重程度评分>4分 vs ≤4分(参照):校正HR=0.41(95%CI 0.18-0.92),P=0.031。
  • 初始淋巴细胞计数降低 vs 正常或升高(参照):校正HR=0.14(95%CI 0.03-0.60),P=0.008。

临床应用与阅片要点

  • 对新型冠状病毒肺炎住院患者,初始胸部CT肺严重程度评分>4分及淋巴细胞计数降低提示康复出院率较低、住院时间可能延长。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To identify the initial chest computed tomography (CT) findings and clinical characteristics associated with the course of coronavirus disease 2019 (COVID-19) pneumonia.

MATERIALS AND METHODS: Baseline CT scans and clinical and laboratory data of 72 patients admitted with COVID-19 pneumonia (39 men, 46.2 ± 15.9 years) were retrospectively analyzed. Baseline CT findings including lobar distribution, presence of ground glass opacities, consolidation, linear opacities, and lung severity score were evaluated. The outcome event was recovery with hospital discharge. The time from symptom onset to discharge or the end of follow-up (for those remained hospitalized) was recorded. Data were censored in events such as death or discharge without recovery. Multivariable Cox proportional hazard regression was used to explore the association between initial CT, clinical or laboratory findings, and discharge with recovery, whereby hazard ratio (HR) values < 1 indicated a lower rate of discharge at four weeks and longer time until discharge.

RESULTS: Thirty-two patients recovered and were discharged during the study period with a median length of admission of 16 days (range, 9 to 25 days), while the rest remained hospitalized at the end of this study (median, 17.5 days; range, 4 to 27 days). None died during the study period. After controlling for age, onset time, lesion characteristics, number of lung lobes affected, and bilateral involvement, the lung severity score on baseline CT (> 4 vs. ≤ 4 [reference]: adjusted HR = 0.41 [95% confidence interval, CI = 0.18-0.92], p = 0.031) and initial lymphocyte count (reduced vs. normal or elevated [reference]: adjusted HR = 0.14 [95% CI = 0.03-0.60], p = 0.008) were two significant independent factors that influenced recovery and discharge.

CONCLUSION: Lung severity score > 4 and reduced lymphocyte count at initial evaluation were independently associated with a significantly lower rate of recovery and discharge and extended hospitalization in patients admitted for COVID-19 pneumonia.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Liu Z, Jin C, Wu CC, et al. Association between Initial Chest CT or Clinical Features and Clinical Course in Patients with Coronavirus Disease 2019 Pneumonia. Korean J Radiol. 2020. PMID: 32410412. doi:10.3348/kjr.2020.0171

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。